European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Recruiting
Observational Study
Lung Diseases, Interstitial
Pulmonary Alveolar Proteinosis
Pulmonary Eosinophilia
Pulmonary Fibrosis
Respiratory Distress Syndrome, Newborn
Child
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Matthias Griese · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Generation of a common European database and biobank Continous assessment and implementation of guidelines and treatment protocols Establishment of a large observational cohort of chILD patients Determination the value of outcomes used in child Assess treatment variations used, deliver data from defined protocols and linked outcomes
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* all children with suspected or
* verified diagnosis of ILD or
* masquerading as ILD and
* those with rare localized parenchymal lung diseases
Exclusion Criteria:
* other indication as inclusion criteria
Contacts